Cspc Innovation Pharmaceutical Co., Ltd. Class ASZSE: 300765

CSPC Innovation Pharmaceutical: Revenue and profit fell significantly amid market headwinds and rising R&D costs

· Issued by Cspc Innovation Pharmaceutical Co., Ltd. Class A

Revenue and net profit declined sharply year-over-year due to lower caffeine prices, reduced health food sales, and increased R&D expenses, while a major acquisition and private placement are underway.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Cspc Innovation Pharmaceutical Co., Ltd. Class A

All Cspc Innovation Pharmaceutical Co., Ltd. Class A news releases